Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [The immunology of malignant melanoma (author's transl)].

× No keyword cloud information.

185 in total

1. The specificity of surface membrane immunofluorescence in human malignant melanoma.

Authors: M G Lewis; T M Phillips
Journal: Int J Cancer Date: 1972-07-15 Impact factor: 7.396

2. In vitro lymphocyte response to autologous cultured lymphoid cells.

Authors: T Han; G E Moore; J E Sokal
Journal: Proc Soc Exp Biol Med Date: 1971-03

3. Hazard of immunosuppressive therapy.

Authors: N Manny; E Rosenman; J Benbassat
Journal: Br Med J Date: 1972-04-29

4. Light and electron microscopic studies of a transplantable melanoma associated with virus-like particles.

Authors: W L Epstein; K Fukuyama
Journal: Cancer Res Date: 1970-05 Impact factor: 12.701

5. Smooth muscle antibody in malignant disease.

Authors: J M Whitehouse; E J Holborow
Journal: Br Med J Date: 1971-11-27

6. Immune studies in malignant melanoma.

Authors: J Blake
Journal: Br J Surg Date: 1971-11 Impact factor: 6.939

7. Cellular and humoral immunity against human malignant melanoma.

Authors: G Fossati; M I Colnaghi; G D Porta; N Cascinelli; U Veronesi
Journal: Int J Cancer Date: 1971-09-15 Impact factor: 7.396

8. Induced remission of malignant melanoma with actinomycin D. Immunologic implications.

Authors: F M Golomb; A C Solowey; A Postel; S L Gumport; J C Wright
Journal: Cancer Date: 1967-05 Impact factor: 6.860

9. Autoimmunization with irradiated tumour cells in human malignant melanoma.

Authors: R L Ikonopisov; M G Lewis; I D Hunter-Craig; D C Bodenham; T M Phillips; C I Cooling; J Proctor; G H Fairley; P Alexander
Journal: Br Med J Date: 1970-06-27

10. Immunologic studies in patients with malignant melanoma in Uganda.

Authors: J L Ziegler; M G Lewis; J M Luyombya; J W Kiryabwire
Journal: Br J Cancer Date: 1969-12 Impact factor: 7.640

2 in total

1. [Cellular immunity in melanomalignome (author's transl)].

Authors: J Fritz; K Grond; G P Tilz
Journal: Arch Dermatol Res Date: 1976-04-21 Impact factor: 3.017

2. Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.

Authors: W Weber; H P Missmahl; B Mazloumi
Journal: Klin Wochenschr Date: 1978-09-15

2 in total